What Is the PINK ETF? A Complete Guide to Returns, Fees, Holdings, and Alternative ETFs
The Simplify Health Care ETF (PINK) is an actively managed ETF in which the portfolio team hand-picks US pharmaceutical and biotech companies. It donates a portion of its distributions to cancer research, and the key factors in choosing it are how its management fee and dividend strategy differ from passive healthcare ETFs such as XLV and VHT.
What Is the Simplify Health Care ETF?
This is an actively managed ETF that invests with a concentrated focus on the US healthcare sector. The portfolio team selects and holds companies that develop new therapies or improve the cost and quality of healthcare systems, and it allocates most of its assets to US healthcare companies.
It suits investors who want to bet on the long-term growth of the healthcare sector but prefer the portfolio team's stock selection over index tracking.
It is an ETF run by Simplify using an active management approach.
How Does the Simplify Health Care ETF Invest?
| Item | Details |
|---|---|
| Tracking Index | Does not track a specific index (active management) |
| Management Style | Active (stock selection) |
| Rebalancing Frequency | At the portfolio team's discretion |
| Dividend Frequency | Irregular distributions |
| Expense Ratio | 0.51% |
| Issuer | Simplify |
Rather than replicating an index, the portfolio team hand-picks companies with medical breakthroughs and business models that lower healthcare costs or raise quality. It builds a diversified portfolio spanning pharmaceuticals and biotech, and a key feature is that a substantial portion of assets is allocated to US healthcare companies.
- Active stock selection without index replication
- A structure that donates a portion of distributions to cancer research organizations
Simplify Health Care ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) are $334.7M, and the expense ratio is 0.51% per year.
Its management fee tends to be higher than that of the passive healthcare ETFs XLV and VHT, but it is differentiated by active selection by the portfolio team rather than index replication.
Simplify Health Care ETF Performance and Trends
The healthcare sector shows volatility depending on clinical trial results and the regulatory environment for pharmaceuticals and biotech, and because of its active selection structure, its performance can diverge from the broader market. Short-term results depend heavily on the momentum of its holdings.
Healthcare is a sector where defensive characteristics and innovative growth coexist, so the direction of fund flows varies with market conditions. As an active ETF, its fund flows tend to react sensitively to management performance.
Simplify Health Care ETF Pros and Cons
The portfolio team's active healthcare selection is its strength, while higher fees than passive funds and dependence on active management performance are its weaknesses.
💪 Key Strengths
⚠️ Points to Watch
Simplify Health Care ETF Alternatives and Related Products
The three tickers shown in the table, XLV, VHT, and IYH, are lower-cost, broad passive ETFs that track the healthcare sector as a whole through an index, and they differ from this ETF in management style and fees. For a focus on biotech, XBI, which is more volatile, is presented in the table, and for the medical device segment, IHI is included as well. In addition, FHLC, a passive fund-type direct substitute for the healthcare sector, and RSPH, which offers equal-weighted exposure, are also worth considering.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| State Street Health Care Select Sector SPDR ETF | $181.17 | -2.2% | $49.6B | 0.08% | 1.41% | +18.7% | |
| Vanguard Health Care ETF | $334.34 | -2.0% | $21.0B | 0.09% | 1.38% | +17.8% | |
| State Street SPDR S&P Biotech ETF | $145.04 | -0.2% | $9.7B | 0.35% | 0.38% | +25.9% | |
| iShares U.S. Healthcare ETF | $75.75 | -2.1% | $4.8B | 0.37% | 1.05% | +18.0% | |
| Fidelity MSCI Health Care Index ETF | $86.45 | -2.0% | $4.1B | 0.08% | 1.18% | +18.2% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | 0.16% | $577.34 | -1.2% | $24.6B | 21.8 | - | |
| Align Technology Inc | 0.08% | $163.96 | +0.3% | $11.6B | 23.8 | - | |
| PureCycle Technologies Inc | 0.07% | $1.82 | +2.3% | $365.8M | - | - | |
| NVO | Novo Nordisk ADR | 0.07% | $39.43 | -3.1% | $131.9B | 9.9 | 4.46% |
| LLY | Lilly(Eli) & Co | 0.13% | $1382.75 | -2.3% | $1.30T | 45.4 | 0.49% |
| UNH | Unitedhealth Group Inc | 0.06% | $349.91 | -10.2% | $313.5B | 20.0 | 2.57% |
| Warby Parker Inc | 0.05% | $28.22 | +8.9% | $3.5B | 484.1 | - | |
| JNJ | Johnson & Johnson | 0.05% | $272.70 | -2.1% | $656.5B | 41.4 | 1.96% |
Simplify Health Care ETF Investor Checkpoints
Here are the points to review before investing in PINK. Because it is an active healthcare ETF, it is wise to thoroughly check the fee difference versus passive funds, the non-index-replicating management style, and its concentration in a single sector in advance, and to confirm that it fits your own investment profile.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 💵 Expense Ratio | Check the cost difference versus passive healthcare ETFs | Somewhat high |
| 🔬 Management Style | Understand active selection rather than index tracking | Active management |
| 📊 Sector Concentration | Check concentration in the single healthcare sector | Sector concentrated |
| 💱 Exchange Rate | Impact on returns converted to Korean won | No currency hedge |
Concentration in the healthcare sector and dependence on active management performance are the main sources of volatility. Clinical trial failures or regulatory changes can directly affect the value of its holdings.
It suits investors who prefer the portfolio team's healthcare stock selection over simple index tracking. If you prioritize cost and diversification, you can consider passive alternatives such as XLV and VHT, and if you want active selection, you can consider this ETF.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of June 11, 2026.